Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes Article Swipe
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.2337/db20-1220
Diabetic retinopathy is one of the leading causes of vision loss and blindness. Extensive preclinical and clinical evidence exists for both vascular and neuronal pathology. However, the relationship of these changes in the neurovascular unit and impact on vision remains to be determined. Here, we investigate the role of tight junction protein occludin phosphorylation at S490 in modulating barrier properties and its impact on visual function. Conditional vascular expression of the phosphorylation-resistant Ser490 to Ala (S490A) form of occludin preserved tight junction organization and reduced vascular endothelial growth factor (VEGF)-induced permeability and edema formation after intraocular injection. In the retinas of streptozotocin-induced diabetic mice, endothelial-specific expression of the S490A form of occludin completely prevented diabetes-induced permeability to labeled dextran and inhibited leukostasis. Importantly, vascular-specific expression of the occludin mutant completely blocked the diabetes-induced decrease in visual acuity and contrast sensitivity. Together, these results reveal that occludin acts to regulate barrier properties downstream of VEGF in a phosphorylation-dependent manner and that loss of inner blood-retinal barrier integrity induced by diabetes contributes to vision loss.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2337/db20-1220
- https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdf
- OA Status
- bronze
- Cited By
- 23
- References
- 54
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3154311708
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3154311708Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2337/db20-1220Digital Object Identifier
- Title
-
Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in DiabetesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-04-21Full publication date if available
- Authors
-
Andreia Gonçalves, Alyssa Dreffs, Cheng‐mao Lin, Sarah Sheskey, Natalie Hudson, Jason M. Keil, Matthew Campbell, David A. AntonettiList of authors in order
- Landing page
-
https://doi.org/10.2337/db20-1220Publisher landing page
- PDF URL
-
https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdfDirect OA link when available
- Concepts
-
Occludin, Tight junction, Vascular permeability, Blood–retinal barrier, Vascular endothelial growth factor, Barrier function, Phosphorylation, Diabetic retinopathy, Cell biology, Retina, Leukostasis, Blood–brain barrier, Edema, Diabetes mellitus, Biology, Retinal, Endocrinology, Internal medicine, Medicine, Ophthalmology, Neuroscience, VEGF receptors, Central nervous systemTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
23Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 6, 2023: 5, 2022: 6, 2021: 2Per-year citation counts (last 5 years)
- References (count)
-
54Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3154311708 |
|---|---|
| doi | https://doi.org/10.2337/db20-1220 |
| ids.doi | https://doi.org/10.2337/db20-1220 |
| ids.mag | 3154311708 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33883214 |
| ids.openalex | https://openalex.org/W3154311708 |
| fwci | 2.40745536 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000818 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Animals |
| mesh[1].qualifier_ui | Q000502 |
| mesh[1].descriptor_ui | D001813 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | physiology |
| mesh[1].descriptor_name | Blood-Retinal Barrier |
| mesh[2].qualifier_ui | Q000503 |
| mesh[2].descriptor_ui | D003921 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | physiopathology |
| mesh[2].descriptor_name | Diabetes Mellitus, Experimental |
| mesh[3].qualifier_ui | Q000503 |
| mesh[3].descriptor_ui | D003930 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | physiopathology |
| mesh[3].descriptor_name | Diabetic Retinopathy |
| mesh[4].qualifier_ui | Q000517 |
| mesh[4].descriptor_ui | D018921 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | prevention & control |
| mesh[4].descriptor_name | Leukostasis |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D051379 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Mice |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008810 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Mice, Inbred C57BL |
| mesh[7].qualifier_ui | Q000502 |
| mesh[7].descriptor_ui | D062793 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | physiology |
| mesh[7].descriptor_name | Occludin |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D010539 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Permeability |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D010766 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Phosphorylation |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D013311 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Streptozocin |
| mesh[11].qualifier_ui | Q000502 |
| mesh[11].descriptor_ui | D042461 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | physiology |
| mesh[11].descriptor_name | Vascular Endothelial Growth Factor A |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D014792 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Visual Acuity |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000818 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Animals |
| mesh[14].qualifier_ui | Q000502 |
| mesh[14].descriptor_ui | D001813 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | physiology |
| mesh[14].descriptor_name | Blood-Retinal Barrier |
| mesh[15].qualifier_ui | Q000503 |
| mesh[15].descriptor_ui | D003921 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | physiopathology |
| mesh[15].descriptor_name | Diabetes Mellitus, Experimental |
| mesh[16].qualifier_ui | Q000503 |
| mesh[16].descriptor_ui | D003930 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | physiopathology |
| mesh[16].descriptor_name | Diabetic Retinopathy |
| mesh[17].qualifier_ui | Q000517 |
| mesh[17].descriptor_ui | D018921 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | prevention & control |
| mesh[17].descriptor_name | Leukostasis |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D051379 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Mice |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D008810 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Mice, Inbred C57BL |
| mesh[20].qualifier_ui | Q000502 |
| mesh[20].descriptor_ui | D062793 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | physiology |
| mesh[20].descriptor_name | Occludin |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D010539 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Permeability |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D010766 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Phosphorylation |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D013311 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Streptozocin |
| mesh[24].qualifier_ui | Q000502 |
| mesh[24].descriptor_ui | D042461 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | physiology |
| mesh[24].descriptor_name | Vascular Endothelial Growth Factor A |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D014792 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Visual Acuity |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D000818 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Animals |
| mesh[27].qualifier_ui | Q000502 |
| mesh[27].descriptor_ui | D001813 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | physiology |
| mesh[27].descriptor_name | Blood-Retinal Barrier |
| mesh[28].qualifier_ui | Q000503 |
| mesh[28].descriptor_ui | D003921 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | physiopathology |
| mesh[28].descriptor_name | Diabetes Mellitus, Experimental |
| mesh[29].qualifier_ui | Q000503 |
| mesh[29].descriptor_ui | D003930 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | physiopathology |
| mesh[29].descriptor_name | Diabetic Retinopathy |
| mesh[30].qualifier_ui | Q000517 |
| mesh[30].descriptor_ui | D018921 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | prevention & control |
| mesh[30].descriptor_name | Leukostasis |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D051379 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Mice |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D008810 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Mice, Inbred C57BL |
| mesh[33].qualifier_ui | Q000502 |
| mesh[33].descriptor_ui | D062793 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | physiology |
| mesh[33].descriptor_name | Occludin |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D010539 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Permeability |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D010766 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Phosphorylation |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D013311 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Streptozocin |
| mesh[37].qualifier_ui | Q000502 |
| mesh[37].descriptor_ui | D042461 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | physiology |
| mesh[37].descriptor_name | Vascular Endothelial Growth Factor A |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D014792 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Visual Acuity |
| type | article |
| title | Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes |
| biblio.issue | 7 |
| biblio.volume | 70 |
| biblio.last_page | 1560 |
| biblio.first_page | 1549 |
| topics[0].id | https://openalex.org/T11872 |
| topics[0].field.id | https://openalex.org/fields/28 |
| topics[0].field.display_name | Neuroscience |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2808 |
| topics[0].subfield.display_name | Neurology |
| topics[0].display_name | Barrier Structure and Function Studies |
| topics[1].id | https://openalex.org/T10170 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9977999925613403 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2731 |
| topics[1].subfield.display_name | Ophthalmology |
| topics[1].display_name | Retinal Diseases and Treatments |
| topics[2].id | https://openalex.org/T14144 |
| topics[2].field.id | https://openalex.org/fields/28 |
| topics[2].field.display_name | Neuroscience |
| topics[2].score | 0.9951000213623047 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2808 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Neurological Disease Mechanisms and Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2775962179 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9858137369155884 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q2013337 |
| concepts[0].display_name | Occludin |
| concepts[1].id | https://openalex.org/C177779419 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7191956639289856 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1053832 |
| concepts[1].display_name | Tight junction |
| concepts[2].id | https://openalex.org/C113045295 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6977449059486389 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7916465 |
| concepts[2].display_name | Vascular permeability |
| concepts[3].id | https://openalex.org/C2778371105 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5848050117492676 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1622103 |
| concepts[3].display_name | Blood–retinal barrier |
| concepts[4].id | https://openalex.org/C2777025900 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5520999431610107 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q29725 |
| concepts[4].display_name | Vascular endothelial growth factor |
| concepts[5].id | https://openalex.org/C51911345 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5060929656028748 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q4863604 |
| concepts[5].display_name | Barrier function |
| concepts[6].id | https://openalex.org/C11960822 |
| concepts[6].level | 2 |
| concepts[6].score | 0.502802848815918 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q242736 |
| concepts[6].display_name | Phosphorylation |
| concepts[7].id | https://openalex.org/C2779829184 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4725603461265564 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q631361 |
| concepts[7].display_name | Diabetic retinopathy |
| concepts[8].id | https://openalex.org/C95444343 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4660184681415558 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[8].display_name | Cell biology |
| concepts[9].id | https://openalex.org/C2777093970 |
| concepts[9].level | 2 |
| concepts[9].score | 0.46143293380737305 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q169342 |
| concepts[9].display_name | Retina |
| concepts[10].id | https://openalex.org/C2777432695 |
| concepts[10].level | 3 |
| concepts[10].score | 0.4472787380218506 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q3237103 |
| concepts[10].display_name | Leukostasis |
| concepts[11].id | https://openalex.org/C2778402981 |
| concepts[11].level | 3 |
| concepts[11].score | 0.41879206895828247 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q221694 |
| concepts[11].display_name | Blood–brain barrier |
| concepts[12].id | https://openalex.org/C2780886150 |
| concepts[12].level | 2 |
| concepts[12].score | 0.41192105412483215 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q152234 |
| concepts[12].display_name | Edema |
| concepts[13].id | https://openalex.org/C555293320 |
| concepts[13].level | 2 |
| concepts[13].score | 0.40732327103614807 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[13].display_name | Diabetes mellitus |
| concepts[14].id | https://openalex.org/C86803240 |
| concepts[14].level | 0 |
| concepts[14].score | 0.3982158303260803 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[14].display_name | Biology |
| concepts[15].id | https://openalex.org/C2780827179 |
| concepts[15].level | 2 |
| concepts[15].score | 0.3960321545600891 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q422001 |
| concepts[15].display_name | Retinal |
| concepts[16].id | https://openalex.org/C134018914 |
| concepts[16].level | 1 |
| concepts[16].score | 0.38326209783554077 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[16].display_name | Endocrinology |
| concepts[17].id | https://openalex.org/C126322002 |
| concepts[17].level | 1 |
| concepts[17].score | 0.35561513900756836 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[17].display_name | Internal medicine |
| concepts[18].id | https://openalex.org/C71924100 |
| concepts[18].level | 0 |
| concepts[18].score | 0.3305642604827881 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[18].display_name | Medicine |
| concepts[19].id | https://openalex.org/C118487528 |
| concepts[19].level | 1 |
| concepts[19].score | 0.23620709776878357 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q161437 |
| concepts[19].display_name | Ophthalmology |
| concepts[20].id | https://openalex.org/C169760540 |
| concepts[20].level | 1 |
| concepts[20].score | 0.20326700806617737 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[20].display_name | Neuroscience |
| concepts[21].id | https://openalex.org/C167734588 |
| concepts[21].level | 2 |
| concepts[21].score | 0.05640789866447449 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q4356503 |
| concepts[21].display_name | VEGF receptors |
| concepts[22].id | https://openalex.org/C529278444 |
| concepts[22].level | 2 |
| concepts[22].score | 0.0 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q47273 |
| concepts[22].display_name | Central nervous system |
| keywords[0].id | https://openalex.org/keywords/occludin |
| keywords[0].score | 0.9858137369155884 |
| keywords[0].display_name | Occludin |
| keywords[1].id | https://openalex.org/keywords/tight-junction |
| keywords[1].score | 0.7191956639289856 |
| keywords[1].display_name | Tight junction |
| keywords[2].id | https://openalex.org/keywords/vascular-permeability |
| keywords[2].score | 0.6977449059486389 |
| keywords[2].display_name | Vascular permeability |
| keywords[3].id | https://openalex.org/keywords/blood–retinal-barrier |
| keywords[3].score | 0.5848050117492676 |
| keywords[3].display_name | Blood–retinal barrier |
| keywords[4].id | https://openalex.org/keywords/vascular-endothelial-growth-factor |
| keywords[4].score | 0.5520999431610107 |
| keywords[4].display_name | Vascular endothelial growth factor |
| keywords[5].id | https://openalex.org/keywords/barrier-function |
| keywords[5].score | 0.5060929656028748 |
| keywords[5].display_name | Barrier function |
| keywords[6].id | https://openalex.org/keywords/phosphorylation |
| keywords[6].score | 0.502802848815918 |
| keywords[6].display_name | Phosphorylation |
| keywords[7].id | https://openalex.org/keywords/diabetic-retinopathy |
| keywords[7].score | 0.4725603461265564 |
| keywords[7].display_name | Diabetic retinopathy |
| keywords[8].id | https://openalex.org/keywords/cell-biology |
| keywords[8].score | 0.4660184681415558 |
| keywords[8].display_name | Cell biology |
| keywords[9].id | https://openalex.org/keywords/retina |
| keywords[9].score | 0.46143293380737305 |
| keywords[9].display_name | Retina |
| keywords[10].id | https://openalex.org/keywords/leukostasis |
| keywords[10].score | 0.4472787380218506 |
| keywords[10].display_name | Leukostasis |
| keywords[11].id | https://openalex.org/keywords/blood–brain-barrier |
| keywords[11].score | 0.41879206895828247 |
| keywords[11].display_name | Blood–brain barrier |
| keywords[12].id | https://openalex.org/keywords/edema |
| keywords[12].score | 0.41192105412483215 |
| keywords[12].display_name | Edema |
| keywords[13].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[13].score | 0.40732327103614807 |
| keywords[13].display_name | Diabetes mellitus |
| keywords[14].id | https://openalex.org/keywords/biology |
| keywords[14].score | 0.3982158303260803 |
| keywords[14].display_name | Biology |
| keywords[15].id | https://openalex.org/keywords/retinal |
| keywords[15].score | 0.3960321545600891 |
| keywords[15].display_name | Retinal |
| keywords[16].id | https://openalex.org/keywords/endocrinology |
| keywords[16].score | 0.38326209783554077 |
| keywords[16].display_name | Endocrinology |
| keywords[17].id | https://openalex.org/keywords/internal-medicine |
| keywords[17].score | 0.35561513900756836 |
| keywords[17].display_name | Internal medicine |
| keywords[18].id | https://openalex.org/keywords/medicine |
| keywords[18].score | 0.3305642604827881 |
| keywords[18].display_name | Medicine |
| keywords[19].id | https://openalex.org/keywords/ophthalmology |
| keywords[19].score | 0.23620709776878357 |
| keywords[19].display_name | Ophthalmology |
| keywords[20].id | https://openalex.org/keywords/neuroscience |
| keywords[20].score | 0.20326700806617737 |
| keywords[20].display_name | Neuroscience |
| keywords[21].id | https://openalex.org/keywords/vegf-receptors |
| keywords[21].score | 0.05640789866447449 |
| keywords[21].display_name | VEGF receptors |
| language | en |
| locations[0].id | doi:10.2337/db20-1220 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S129060628 |
| locations[0].source.issn | 0012-1797, 1939-327X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0012-1797 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Diabetes |
| locations[0].source.host_organization | https://openalex.org/P4310320274 |
| locations[0].source.host_organization_name | American Diabetes Association |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320274 |
| locations[0].license | |
| locations[0].pdf_url | https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Diabetes |
| locations[0].landing_page_url | https://doi.org/10.2337/db20-1220 |
| locations[1].id | pmid:33883214 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Diabetes |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33883214 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8336002 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Diabetes |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8336002 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5006745683 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3673-1687 |
| authorships[0].author.display_name | Andreia Gonçalves |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[0].institutions[0].id | https://openalex.org/I27837315 |
| authorships[0].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Michigan |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Andreia Goncalves |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[1].author.id | https://openalex.org/A5083871903 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Alyssa Dreffs |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[1].institutions[0].id | https://openalex.org/I27837315 |
| authorships[1].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Michigan |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Alyssa Dreffs |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[2].author.id | https://openalex.org/A5056910741 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2409-9423 |
| authorships[2].author.display_name | Cheng‐mao Lin |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[2].institutions[0].id | https://openalex.org/I27837315 |
| authorships[2].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of Michigan |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Cheng-mao Lin |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[3].author.id | https://openalex.org/A5031517671 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-3394-4174 |
| authorships[3].author.display_name | Sarah Sheskey |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[3].institutions[0].id | https://openalex.org/I27837315 |
| authorships[3].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of Michigan |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Sarah Sheskey |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[4].author.id | https://openalex.org/A5059823425 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Natalie Hudson |
| authorships[4].countries | IE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I205274468 |
| authorships[4].affiliations[0].raw_affiliation_string | Neurovascular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland |
| authorships[4].institutions[0].id | https://openalex.org/I205274468 |
| authorships[4].institutions[0].ror | https://ror.org/02tyrky19 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I205274468 |
| authorships[4].institutions[0].country_code | IE |
| authorships[4].institutions[0].display_name | Trinity College Dublin |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Natalie Hudson |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Neurovascular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland |
| authorships[5].author.id | https://openalex.org/A5035122303 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-3431-5540 |
| authorships[5].author.display_name | Jason M. Keil |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[5].institutions[0].id | https://openalex.org/I27837315 |
| authorships[5].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of Michigan |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jason Keil |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[6].author.id | https://openalex.org/A5009631835 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3325-240X |
| authorships[6].author.display_name | Matthew Campbell |
| authorships[6].countries | IE |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I205274468 |
| authorships[6].affiliations[0].raw_affiliation_string | Neurovascular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland |
| authorships[6].institutions[0].id | https://openalex.org/I205274468 |
| authorships[6].institutions[0].ror | https://ror.org/02tyrky19 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I205274468 |
| authorships[6].institutions[0].country_code | IE |
| authorships[6].institutions[0].display_name | Trinity College Dublin |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Matthew Campbell |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Neurovascular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland |
| authorships[7].author.id | https://openalex.org/A5081193362 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1130-6577 |
| authorships[7].author.display_name | David A. Antonetti |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I27837315 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| authorships[7].institutions[0].id | https://openalex.org/I27837315 |
| authorships[7].institutions[0].ror | https://ror.org/00jmfr291 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I27837315 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | University of Michigan |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | David A. Antonetti |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor, MI |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Vascular Expression of Permeability-Resistant Occludin Mutant Preserves Visual Function in Diabetes |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11872 |
| primary_topic.field.id | https://openalex.org/fields/28 |
| primary_topic.field.display_name | Neuroscience |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2808 |
| primary_topic.subfield.display_name | Neurology |
| primary_topic.display_name | Barrier Structure and Function Studies |
| related_works | https://openalex.org/W2204941821, https://openalex.org/W2581294806, https://openalex.org/W4256565063, https://openalex.org/W7527365, https://openalex.org/W2742223661, https://openalex.org/W2312108116, https://openalex.org/W2169265493, https://openalex.org/W4251987214, https://openalex.org/W3154311708, https://openalex.org/W4255466287 |
| cited_by_count | 23 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 5 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 6 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | doi:10.2337/db20-1220 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S129060628 |
| best_oa_location.source.issn | 0012-1797, 1939-327X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0012-1797 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Diabetes |
| best_oa_location.source.host_organization | https://openalex.org/P4310320274 |
| best_oa_location.source.host_organization_name | American Diabetes Association |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320274 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Diabetes |
| best_oa_location.landing_page_url | https://doi.org/10.2337/db20-1220 |
| primary_location.id | doi:10.2337/db20-1220 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S129060628 |
| primary_location.source.issn | 0012-1797, 1939-327X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0012-1797 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Diabetes |
| primary_location.source.host_organization | https://openalex.org/P4310320274 |
| primary_location.source.host_organization_name | American Diabetes Association |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320274 |
| primary_location.license | |
| primary_location.pdf_url | https://diabetesjournals.org/diabetes/article-pdf/70/7/1549/628427/db201220.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Diabetes |
| primary_location.landing_page_url | https://doi.org/10.2337/db20-1220 |
| publication_date | 2021-04-21 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W2794677028, https://openalex.org/W1993968665, https://openalex.org/W1615720065, https://openalex.org/W2738328909, https://openalex.org/W2127418688, https://openalex.org/W2324588265, https://openalex.org/W2105822541, https://openalex.org/W2885537851, https://openalex.org/W2178156144, https://openalex.org/W6632444561, https://openalex.org/W1272063813, https://openalex.org/W1786299986, https://openalex.org/W2171818522, https://openalex.org/W2041225773, https://openalex.org/W1985907458, https://openalex.org/W2142613038, https://openalex.org/W1979286544, https://openalex.org/W1967709839, https://openalex.org/W2965152158, https://openalex.org/W2470657018, https://openalex.org/W2087899702, https://openalex.org/W2167747754, https://openalex.org/W6808230964, https://openalex.org/W2785933318, https://openalex.org/W4244017022, https://openalex.org/W2049823612, https://openalex.org/W2765364956, https://openalex.org/W2254397565, https://openalex.org/W2169186082, https://openalex.org/W2051776965, https://openalex.org/W2083101794, https://openalex.org/W2107154293, https://openalex.org/W2163830368, https://openalex.org/W2106203228, https://openalex.org/W2110114499, https://openalex.org/W2616361514, https://openalex.org/W1782108791, https://openalex.org/W2014878084, https://openalex.org/W1578810619, https://openalex.org/W2039517564, https://openalex.org/W2763524741, https://openalex.org/W2091695488, https://openalex.org/W2017629171, https://openalex.org/W6628212988, https://openalex.org/W2892153706, https://openalex.org/W1971775352, https://openalex.org/W2106013244, https://openalex.org/W1977894531, https://openalex.org/W4206184245, https://openalex.org/W3134431802, https://openalex.org/W2061356986, https://openalex.org/W1537722773, https://openalex.org/W4211022775, https://openalex.org/W3194071254 |
| referenced_works_count | 54 |
| abstract_inverted_index.a | 155 |
| abstract_inverted_index.In | 97 |
| abstract_inverted_index.at | 54 |
| abstract_inverted_index.be | 41 |
| abstract_inverted_index.by | 167 |
| abstract_inverted_index.in | 31, 56, 134, 154 |
| abstract_inverted_index.is | 2 |
| abstract_inverted_index.of | 4, 8, 28, 48, 69, 77, 100, 106, 110, 125, 152, 161 |
| abstract_inverted_index.on | 37, 63 |
| abstract_inverted_index.to | 40, 73, 116, 147, 170 |
| abstract_inverted_index.we | 44 |
| abstract_inverted_index.Ala | 74 |
| abstract_inverted_index.and | 11, 15, 22, 35, 60, 83, 91, 119, 137, 158 |
| abstract_inverted_index.for | 19 |
| abstract_inverted_index.its | 61 |
| abstract_inverted_index.one | 3 |
| abstract_inverted_index.the | 5, 26, 32, 46, 70, 98, 107, 126, 131 |
| abstract_inverted_index.S490 | 55 |
| abstract_inverted_index.VEGF | 153 |
| abstract_inverted_index.acts | 146 |
| abstract_inverted_index.both | 20 |
| abstract_inverted_index.form | 76, 109 |
| abstract_inverted_index.loss | 10, 160 |
| abstract_inverted_index.role | 47 |
| abstract_inverted_index.that | 144, 159 |
| abstract_inverted_index.unit | 34 |
| abstract_inverted_index.Here, | 43 |
| abstract_inverted_index.S490A | 108 |
| abstract_inverted_index.after | 94 |
| abstract_inverted_index.edema | 92 |
| abstract_inverted_index.inner | 162 |
| abstract_inverted_index.loss. | 172 |
| abstract_inverted_index.mice, | 103 |
| abstract_inverted_index.these | 29, 141 |
| abstract_inverted_index.tight | 49, 80 |
| abstract_inverted_index.Ser490 | 72 |
| abstract_inverted_index.acuity | 136 |
| abstract_inverted_index.causes | 7 |
| abstract_inverted_index.exists | 18 |
| abstract_inverted_index.factor | 88 |
| abstract_inverted_index.growth | 87 |
| abstract_inverted_index.impact | 36, 62 |
| abstract_inverted_index.manner | 157 |
| abstract_inverted_index.mutant | 128 |
| abstract_inverted_index.reveal | 143 |
| abstract_inverted_index.vision | 9, 38, 171 |
| abstract_inverted_index.visual | 64, 135 |
| abstract_inverted_index.(S490A) | 75 |
| abstract_inverted_index.barrier | 58, 149, 164 |
| abstract_inverted_index.blocked | 130 |
| abstract_inverted_index.changes | 30 |
| abstract_inverted_index.dextran | 118 |
| abstract_inverted_index.induced | 166 |
| abstract_inverted_index.labeled | 117 |
| abstract_inverted_index.leading | 6 |
| abstract_inverted_index.protein | 51 |
| abstract_inverted_index.reduced | 84 |
| abstract_inverted_index.remains | 39 |
| abstract_inverted_index.results | 142 |
| abstract_inverted_index.retinas | 99 |
| abstract_inverted_index.Diabetic | 0 |
| abstract_inverted_index.However, | 25 |
| abstract_inverted_index.clinical | 16 |
| abstract_inverted_index.contrast | 138 |
| abstract_inverted_index.decrease | 133 |
| abstract_inverted_index.diabetes | 168 |
| abstract_inverted_index.diabetic | 102 |
| abstract_inverted_index.evidence | 17 |
| abstract_inverted_index.junction | 50, 81 |
| abstract_inverted_index.neuronal | 23 |
| abstract_inverted_index.occludin | 52, 78, 111, 127, 145 |
| abstract_inverted_index.regulate | 148 |
| abstract_inverted_index.vascular | 21, 67, 85 |
| abstract_inverted_index.Extensive | 13 |
| abstract_inverted_index.Together, | 140 |
| abstract_inverted_index.formation | 93 |
| abstract_inverted_index.function. | 65 |
| abstract_inverted_index.inhibited | 120 |
| abstract_inverted_index.integrity | 165 |
| abstract_inverted_index.preserved | 79 |
| abstract_inverted_index.prevented | 113 |
| abstract_inverted_index.blindness. | 12 |
| abstract_inverted_index.completely | 112, 129 |
| abstract_inverted_index.downstream | 151 |
| abstract_inverted_index.expression | 68, 105, 124 |
| abstract_inverted_index.injection. | 96 |
| abstract_inverted_index.modulating | 57 |
| abstract_inverted_index.pathology. | 24 |
| abstract_inverted_index.properties | 59, 150 |
| abstract_inverted_index.Conditional | 66 |
| abstract_inverted_index.contributes | 169 |
| abstract_inverted_index.determined. | 42 |
| abstract_inverted_index.endothelial | 86 |
| abstract_inverted_index.intraocular | 95 |
| abstract_inverted_index.investigate | 45 |
| abstract_inverted_index.preclinical | 14 |
| abstract_inverted_index.retinopathy | 1 |
| abstract_inverted_index.Importantly, | 122 |
| abstract_inverted_index.leukostasis. | 121 |
| abstract_inverted_index.organization | 82 |
| abstract_inverted_index.permeability | 90, 115 |
| abstract_inverted_index.relationship | 27 |
| abstract_inverted_index.sensitivity. | 139 |
| abstract_inverted_index.blood-retinal | 163 |
| abstract_inverted_index.neurovascular | 33 |
| abstract_inverted_index.(VEGF)-induced | 89 |
| abstract_inverted_index.phosphorylation | 53 |
| abstract_inverted_index.diabetes-induced | 114, 132 |
| abstract_inverted_index.vascular-specific | 123 |
| abstract_inverted_index.endothelial-specific | 104 |
| abstract_inverted_index.streptozotocin-induced | 101 |
| abstract_inverted_index.phosphorylation-dependent | 156 |
| abstract_inverted_index.phosphorylation-resistant | 71 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 93 |
| corresponding_author_ids | https://openalex.org/A5006745683 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 8 |
| corresponding_institution_ids | https://openalex.org/I27837315 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.84900317 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |